{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:30:58Z","timestamp":1767839458330,"version":"3.49.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2020jscx-fyzx0053"],"award-info":[{"award-number":["cstc2020jscx-fyzx0053"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["CYS21244"],"award-info":[{"award-number":["CYS21244"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["KJCXZD2020018"],"award-info":[{"award-number":["KJCXZD2020018"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002131"],"award-info":[{"award-number":["82002131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["CQMUNCP0207"],"award-info":[{"award-number":["CQMUNCP0207"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["cstc2020jcyj-msxmX0081"],"award-info":[{"award-number":["cstc2020jcyj-msxmX0081"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing pandemic that poses a great threat to human health worldwide. As the humoral immune response plays essential roles in disease occurrence and development, understanding the dynamics and characteristics of virus-specific humoral immunity in SARS-CoV-2-infected patients is of great importance for controlling this disease. In this review, we summarize the characteristics of the humoral immune response after SARS-CoV-2 infection and further emphasize the potential applications and therapeutic prospects of SARS-CoV-2-specific humoral immunity and the critical role of this immunity in vaccine development. Notably, serological antibody testing based on the humoral immune response can guide public health measures and control strategies; however, it is not recommended for population surveys in areas with very low prevalence. Existing evidence suggests that asymptomatic individuals have a weaker immune response to SARS-CoV-2 infection, whereas SARS-CoV-2-infected children have a more effective humoral immune response than adults. The correlations between antibody (especially neutralizing antibody) titers and protection against SARS-CoV-2 reinfection should be further examined. In addition, the emergence of cross-reactions among different coronavirus antigens in the development of screening technology and the risk of antibody-dependent enhancement related to SARS-CoV-2 vaccination should be given further attention.<\/jats:p>","DOI":"10.1038\/s41423-021-00774-w","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T18:57:34Z","timestamp":1634151454000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects"],"prefix":"10.1038","volume":"19","author":[{"given":"Jiaxin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binli","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengji","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9171-0195","authenticated-orcid":false,"given":"Yong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-7423","authenticated-orcid":false,"given":"Ailong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"774_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/jama.2020.1097","volume":"323","author":"AL Phelan","year":"2020","unstructured":"Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020;323:709\u201310.","journal-title":"JAMA"},{"key":"774_CR2","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1038\/s41586-020-2951-z","volume":"588","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. Addendum: a pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;588:E6.","journal-title":"Nature"},{"key":"774_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","volume":"181","author":"YZ Zhang","year":"2020","unstructured":"Zhang YZ, Holmes EC. A genomic perspective on the origin and emergence of SARS-CoV-2. Cell. 2020;181:223\u20137.","journal-title":"Cell"},{"key":"774_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281\u201392.e6.","journal-title":"Cell"},{"key":"774_CR5","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260\u20133.","journal-title":"Science"},{"key":"774_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.immuni.2007.09.002","volume":"27","author":"T Dorner","year":"2007","unstructured":"Dorner T, Radbruch A. Antibodies and B cell memory in viral immunity. Immunity. 2007;27:384\u201392.","journal-title":"Immunity"},{"key":"774_CR7","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.3389\/fimmu.2019.01787","volume":"10","author":"AKE Palm","year":"2019","unstructured":"Palm AKE, Henry C. Remembrance of things past: long-term B cell memory after infection and vaccination. Front Immunol. 2019;10:1787.","journal-title":"Front Immunol"},{"key":"774_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/cid\/ciaa310","volume":"71","author":"L Guo","year":"2020","unstructured":"Guo L, Ren L, Yang S, Xiao M, Chang, Yang F, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020;71:778\u201385.","journal-title":"Clin Infect Dis"},{"key":"774_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265\u20139.","journal-title":"Nature"},{"key":"774_CR10","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S0140-6736(20)30788-1","volume":"395","author":"A Petherick","year":"2020","unstructured":"Petherick A. Developing antibody tests for SARS-CoV-2. Lancet. 2020;395:1101\u20132.","journal-title":"Lancet"},{"key":"774_CR11","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1574-6976.2006.00032.x","volume":"30","author":"L van der Hoek","year":"2006","unstructured":"van der Hoek L, Pyrc K, Berkhout B. Human coronavirus NL63, a new respiratory virus. FEMS Microbiol Rev. 2006;30:760\u201373.","journal-title":"FEMS Microbiol Rev"},{"key":"774_CR12","doi-asserted-by":"publisher","first-page":"2000763","DOI":"10.1183\/13993003.00763-2020","volume":"56","author":"B Lou","year":"2020","unstructured":"Lou B, Li TD, Zheng SF, Su YY, Li ZY, Liu W, et al. Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset. Eur Respir J. 2020;56:2000763.","journal-title":"Eur Respir J"},{"key":"774_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/infdis\/jiaa243","volume":"222","author":"XF Cai","year":"2020","unstructured":"Cai XF, Chen J, Li Hu J, Long QX, Deng HJ, Liu P, et al. A peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis of coronavirus disease 2019. J Infect Dis. 2020;222:189\u201393.","journal-title":"J Infect Dis"},{"key":"774_CR14","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s41587-020-0659-0","volume":"38","author":"JD Whitman","year":"2020","unstructured":"Whitman JD, Hiatt J, Mowery CT, Shy BR, Yu R, Yamamoto TN, et al. Evaluation of SARS-CoV-2 serology assays reveals a range of test performance. Nat Biotechnol. 2020;38:1174\u201383.","journal-title":"Nat Biotechnol"},{"key":"774_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jaci.2020.10.040","volume":"147","author":"C Cervia","year":"2021","unstructured":"Cervia C, Nilsson J, Zurbuchen Y, Valaperti A, Schreiner J, Wolfensberger A, et al. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J Allergy Clin Immunol. 2021;147:545\u201357.e9.","journal-title":"J Allergy Clin Immunol"},{"key":"774_CR16","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","volume":"591","author":"C Gaebler","year":"2021","unstructured":"Gaebler C, Wang Z, Lorenzi J, Muecksch F, Finkin S, Tokuyama M, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639\u201344.","journal-title":"Nature"},{"key":"774_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/v13010026","volume":"13","author":"N Orologas-Stavrou","year":"2020","unstructured":"Orologas-Stavrou N, Politou M, Rousakis P, Kostopoulos IV, Ntanasis-Stathopoulos I, Jahaj E, et al. Peripheral blood immune profiling of convalescent plasma donors reveals alterations in specific immune subpopulations even at 2 months post SARS-CoV-2 infection. Viruses. 2020;13:26.","journal-title":"Viruses"},{"key":"774_CR18","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40291-020-00486-3","volume":"24","author":"LX Zhang","year":"2020","unstructured":"Zhang LX, Miao SY, Qin ZH, Wu JP, Chen HY, Sun HB, et al. Preliminary analysis of B- and T-cell responses to SARS-CoV-2. Mol Diagn Ther. 2020;24:601\u20139.","journal-title":"Mol Diagn Ther"},{"key":"774_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijid.2020.03.065","volume":"94","author":"Y Jin","year":"2020","unstructured":"Jin Y, Wang M, Zuo Z, Fan C, Ye F, Cai Z, et al. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019. Int J Infect Dis. 2020;94:49\u201352.","journal-title":"Int J Infect Dis"},{"key":"774_CR20","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/cid\/ciaa461","volume":"71","author":"F Xiang","year":"2020","unstructured":"Xiang F, Wang X, He X, Peng Z, Yang B, Zhang J, et al. Antibody detection and dynamic characteristics in patients with coronavirus disease 2019. Clin Infect Dis. 2020;71:1930\u20134.","journal-title":"Clin Infect Dis"},{"key":"774_CR21","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41423-020-0474-z","volume":"17","author":"H Ma","year":"2020","unstructured":"Ma H, Zeng W, He H, Zhao D, Jiang D, Zhou P, et al. Serum IgA, IgM, and IgG responses in COVID-19. Cell Mol Immunol. 2020;17:773\u20135.","journal-title":"Cell Mol Immunol"},{"key":"774_CR22","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.chom.2021.06.009","volume":"29","author":"K Roltgen","year":"2021","unstructured":"Roltgen K, Boyd SD. Antibody and B cell responses to SARS-CoV-2 infection and vaccination. Cell Host Microbe. 2021;29:1063\u201375.","journal-title":"Cell Host Microbe"},{"key":"774_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21463-2","volume":"12","author":"J Tang","year":"2021","unstructured":"Tang J, Ravichandran S, Lee Y, Grubbs G, Coyle EM, Klenow L, et al. Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients. Nat Commun. 2021;12:1221.","journal-title":"Nat Commun"},{"key":"774_CR24","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.cell.2020.10.051","volume":"183","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zuiani A, Fischinger S, Mullur J, Atyeo C, Travers M, et al. Quick COVID-19 Healers sustain anti-SARS-CoV-2 antibody production. Cell. 2020;183:1496\u2013507.e16.","journal-title":"Cell"},{"key":"774_CR25","doi-asserted-by":"publisher","first-page":"107271","DOI":"10.1016\/j.intimp.2020.107271","volume":"90","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li J, Li H, Lei P, Shen G, Yang C. Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients. Int Immunopharmacol. 2021;90:107271.","journal-title":"Int Immunopharmacol"},{"key":"774_CR26","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.cell.2020.10.052","volume":"183","author":"T Zohar","year":"2020","unstructured":"Zohar T, Loos C, Fischinger S, Atyeo C, Wang C, Slein MD, et al. Compromised humoral functional evolution tracks with SARS-CoV-2 mortality. Cell. 2020;183:1508\u201319 e12.","journal-title":"Cell"},{"key":"774_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4049\/jimmunol.2000898","volume":"206","author":"CB Hansen","year":"2021","unstructured":"Hansen CB, Jarlhelt I, P\u00e9rez-Al\u00f3s L, Hummelsh\u00f8j Landsy L, Loftager M, Rosbjerg A, et al. SARS-CoV-2 antibody responses are correlated to disease severity in COVID-19 convalescent individuals. J Immunol. 2021;206:109\u201317.","journal-title":"J Immunol"},{"key":"774_CR28","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/cid\/ciaa489","volume":"71","author":"J Qu","year":"2020","unstructured":"Qu J, Wu C, Li X, Zhang G, Jiang Z, Li X, et al. Profile of immunoglobulin G and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71:2255\u20138.","journal-title":"Clin Infect Dis"},{"key":"774_CR29","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","volume":"71","author":"J Zhao","year":"2020","unstructured":"Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020;71:2027\u201334.","journal-title":"Clin Infect Dis"},{"key":"774_CR30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"QX Long","year":"2020","unstructured":"Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26:845\u20138.","journal-title":"Nat Med"},{"key":"774_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/cid\/ciaa979","volume":"72","author":"KL Lynch","year":"2021","unstructured":"Lynch KL, Whitman JD, Lacanienta NP, Beckerdite EW, Kastner SA, Shy BR, et al. Magnitude and kinetics of anti-severe acute respiratory syndrome coronavirus 2 antibody responses and their relationship to disease severity. Clin Infect Dis. 2021;72:301\u20138.","journal-title":"Clin Infect Dis"},{"key":"774_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/15548627.2019.1632104","volume":"16","author":"Y Lin","year":"2020","unstructured":"Lin Y, Wu C, Wang X, Liu S, Zhao K, Kemper T, et al. Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling. Autophagy. 2020;16:548\u201361.","journal-title":"Autophagy"},{"key":"774_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/cid\/ciaa979","volume":"72","author":"KL Lynch","year":"2020","unstructured":"Lynch KL, Whitman JD, Lacanienta NP, Beckerdite EW, Kastner SA, Shy BR, et al. Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity. Clin Infect Dis. 2020;72:301\u20138.","journal-title":"Clin Infect Dis"},{"key":"774_CR34","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1172\/JCI138759","volume":"130","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang L, Sang L, Ye F, Ruan S, Zhong B, et al. Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Investig. 2020;130:5235\u201344.","journal-title":"J Clin Investig"},{"key":"774_CR35","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1172\/JCI139760","volume":"130","author":"A Casadevall","year":"2020","unstructured":"Casadevall A, Joyner MJ, Pirofski LA. SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. J Clin Investig. 2020;130:5112\u20134.","journal-title":"J Clin Investig"},{"key":"774_CR36","doi-asserted-by":"publisher","first-page":"2001526","DOI":"10.1183\/13993003.01526-2020","volume":"56","author":"HQ Yu","year":"2020","unstructured":"Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY, Li YM, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients. Eur Respir J. 2020;56:2001526.","journal-title":"Eur Respir J"},{"key":"774_CR37","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","volume":"26","author":"QX Long","year":"2020","unstructured":"Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200\u20134.","journal-title":"Nat Med"},{"key":"774_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41421-021-00250-9","volume":"7","author":"QX Long","year":"2021","unstructured":"Long QX, Jia YJ, Wang X, Deng HJ, Cao XX, Yuan J, et al. Immune memory in convalescent patients with asymptomatic or mild COVID-19. Cell Discov. 2021;7:18.","journal-title":"Cell Discov"},{"key":"774_CR39","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1002\/eji.202048915","volume":"50","author":"A Mazzoni","year":"2020","unstructured":"Mazzoni A, Maggi L, Capone M, Spinicci M, Salvati L, Colao MG, et al. Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients. Eur J Immunol. 2020;50:2013\u201324.","journal-title":"Eur J Immunol"},{"key":"774_CR40","doi-asserted-by":"publisher","first-page":"573526","DOI":"10.3389\/fimmu.2020.573526","volume":"11","author":"L Sch\u00f6ler","year":"2020","unstructured":"Sch\u00f6ler L, Le-Trilling VTK, Eilbrecht M, Mennerich D, Anastasiou OE, Krawczyk A, et al. A novel in-cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyze neutralizing antibodies and antiviral compounds. Front Immunol. 2020;11:573526.","journal-title":"Front Immunol"},{"key":"774_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3201\/eid2701.203515","volume":"27","author":"PG Choe","year":"2021","unstructured":"Choe PG, Kang CK, Suh HJ, Jung J, Song KH, Bang JH, et al. Waning antibody responses in asymptomatic and symptomatic SARS-CoV-2 infection. Emerg Infect Dis. 2021;27:327\u20139.","journal-title":"Emerg Infect Dis"},{"key":"774_CR42","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41423-020-0438-3","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xu J, Jia R, Yi C, Gu W, Liu P, et al. Protective humoral immunity in SARS-CoV-2 infected pediatric patients. Cell Mol Immunol. 2020;17:768\u201370.","journal-title":"Cell Mol Immunol"},{"key":"774_CR43","doi-asserted-by":"publisher","first-page":"e2010895","DOI":"10.1001\/jamanetworkopen.2020.10895","volume":"3","author":"H Wu","year":"2020","unstructured":"Wu H, Zhu H, Yuan C, Yao C, Luo W, Shen X, et al. Clinical and immune features of hospitalized pediatric patients with coronavirus disease 2019 (COVID-19) in Wuhan, China. JAMA Netw Open. 2020;3:e2010895.","journal-title":"JAMA Netw Open"},{"key":"774_CR44","doi-asserted-by":"publisher","first-page":"108588","DOI":"10.1016\/j.clim.2020.108588","volume":"220","author":"S Felsenstein","year":"2020","unstructured":"Felsenstein S, Hedrich CM. SARS-CoV-2 infections in children and young people. Clin Immunol. 2020;220:108588.","journal-title":"Clin Immunol"},{"key":"774_CR45","doi-asserted-by":"publisher","first-page":"eabd5487","DOI":"10.1126\/scitranslmed.abd5487","volume":"12","author":"CA Pierce","year":"2020","unstructured":"Pierce CA, Preston-Hurlburt P, Dai Y, Aschner CB, Cheshenko N, Galen B, et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci Transl Med. 2020;12:eabd5487.","journal-title":"Sci Transl Med"},{"key":"774_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","volume":"25","author":"VM Corman","year":"2020","unstructured":"Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25:23\u201330.","journal-title":"Eurosurveillance"},{"key":"774_CR47","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1021\/acsnano.0c02624","volume":"14","author":"B Udugama","year":"2020","unstructured":"Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li V, et al. Diagnosing COVID-19: the disease and tools for detection. ACS Nano. 2020;14:3822\u201335.","journal-title":"ACS Nano"},{"key":"774_CR48","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1126\/science.abc1227","volume":"368","author":"F Krammer","year":"2020","unstructured":"Krammer F, Simon V. Serology assays to manage COVID-19. Science. 2020;368:1060\u20131.","journal-title":"Science"},{"key":"774_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2020.06.012","volume":"53","author":"AM Lerner","year":"2020","unstructured":"Lerner AM, Eisinger RW, Lowy DR, Petersen LR, Humes R, Hepburn M, et al. The COVID-19 serology studies workshop: recommendations and challenges. Immunity. 2020;53:1\u20135.","journal-title":"Immunity"},{"key":"774_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41591-020-01178-5","volume":"27","author":"Q Shi","year":"2021","unstructured":"Shi Q, Hu Y, Peng B, Tang XJ, Wang W, Su K, et al. Effective control of SARS-CoV-2 transmission in Wanzhou. China Nat Med. 2021;27:86\u201393.","journal-title":"China Nat Med"},{"key":"774_CR51","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1056\/NEJMoa2026116","volume":"383","author":"DF Gudbjartsson","year":"2020","unstructured":"Gudbjartsson DF, Norddahl GL, Melsted P, Gunnarsdottir K, Holm H, Eythorsson E, et al. Humoral immune response to SARS-CoV-2 in Iceland. N Engl J Med. 2020;383:1724\u201334.","journal-title":"N Engl J Med"},{"key":"774_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","volume":"396","author":"S Stringhini","year":"2020","unstructured":"Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396:313\u20139.","journal-title":"Lancet"},{"key":"774_CR53","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(20)31483-5","volume":"396","author":"M Poll\u00e1n","year":"2020","unstructured":"Poll\u00e1n M, P\u00e9rez-G\u00f3mez B, Pastor-Barriuso R, Oteo J, Hern\u00e1n MA, P\u00e9rez-Olmeda M, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396:535\u201344.","journal-title":"Lancet"},{"key":"774_CR54","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.cell.2020.08.046","volume":"182","author":"C Kreer","year":"2020","unstructured":"Kreer C, Zehner M, Weber T, Ercanoglu MS, Gieselmann L, Rohde C, et al. Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients (vol 182, pg 843, 2020). Cell. 2020;182:1663\u201373.","journal-title":"Cell"},{"key":"774_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","volume":"584","author":"B Ju","year":"2020","unstructured":"Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020;584:115\u2013119.","journal-title":"Nature"},{"key":"774_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16256-y","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang C, Li W, Drabek D, Okba N, van Haperen R, Osterhaus A, et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun. 2020;11:2251.","journal-title":"Nat Commun"},{"key":"774_CR57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","volume":"584","author":"SJ Zost","year":"2020","unstructured":"Zost SJ, Gilchuk P, Case JB, Binshtein E, Chen RE, Nkolola JP, et al. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020;584:443\u20139.","journal-title":"Nature"},{"key":"774_CR58","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.abc6952","volume":"369","author":"X Chi","year":"2020","unstructured":"Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M, et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science. 2020;369:650\u2013655.","journal-title":"Science"},{"key":"774_CR59","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","volume":"396","author":"FC Zhu","year":"2020","unstructured":"Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, et al. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020;396:479\u201388.","journal-title":"Lancet"},{"key":"774_CR60","doi-asserted-by":"publisher","first-page":"e531","DOI":"10.1093\/cid\/ciaa1143","volume":"73","author":"K Wang","year":"2021","unstructured":"Wang K, Long QX, Deng HJ, Hu J, Gao QZ, Zhang GJ, et al. Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection. Clin Infect Dis. 2021;73:e531\u20139.","journal-title":"Clin Infect Dis"},{"key":"774_CR61","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.vaccine.2008.01.025","volume":"26","author":"L Du","year":"2008","unstructured":"Du L, Zhao G, Lin Y, Chan C, He Y, Jiang S, et al. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine. 2008;26:1644\u201351.","journal-title":"Vaccine"},{"key":"774_CR62","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.1128\/JVI.00087-13","volume":"87","author":"C Fett","year":"2013","unstructured":"Fett C, DeDiego ML, Regla-Nava JA, Enjuanes L, Perlman S. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein. J Virol. 2013;87:6551\u20139.","journal-title":"J Virol"},{"key":"774_CR63","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1126\/science.abc4776","volume":"369","author":"A Chandrashekar","year":"2020","unstructured":"Chandrashekar A, Liu J, Martinot AJ, McMahan K, Mercado NB, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;369:812\u20137.","journal-title":"Science"},{"key":"774_CR64","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.abc5343","volume":"369","author":"W Deng","year":"2020","unstructured":"Deng W, Bao L, Liu J, Xiao C, Liu J, Xue J, et al. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020;369:818\u201323.","journal-title":"Science"},{"key":"774_CR65","doi-asserted-by":"publisher","first-page":"eabe0240","DOI":"10.1126\/sciimmunol.abe0240","volume":"5","author":"K R\u00f6ltgen","year":"2020","unstructured":"R\u00f6ltgen K, Powell AE, Wirz OF, Stevens BA, Hogan CA, Najeeb J, et al. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Sci Immunol. 2020;5:eabe0240.","journal-title":"Sci Immunol"},{"key":"774_CR66","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/s41564-020-00813-8","volume":"5","author":"J Seow","year":"2020","unstructured":"Seow J, Graham C, Merrick B, Acors S, Pickering S, Steel K, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020;5:1598\u2013607.","journal-title":"Nat Microbiol"},{"key":"774_CR67","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1172\/JCI138745","volume":"130","author":"EM Bloch","year":"2020","unstructured":"Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Investig. 2020;130:2757\u201365.","journal-title":"J Clin Investig"},{"key":"774_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18450-4","volume":"11","author":"AT Huang","year":"2020","unstructured":"Huang AT, Garcia-Carreras B, Hitchings M, Yang B, Katzelnick LC, Rattigan SM, et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat Commun. 2020;11:4704.","journal-title":"Nat Commun"},{"key":"774_CR69","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/jama.2020.4783","volume":"323","author":"C Shen","year":"2020","unstructured":"Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020;323:1582\u20139.","journal-title":"JAMA"},{"key":"774_CR70","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.cmi.2020.08.005","volume":"26","author":"DJ Wooding","year":"2020","unstructured":"Wooding DJ, Bach H. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks. Clin Microbiol Infect. 2020;26:1436\u201346.","journal-title":"Clin Microbiol Infect"},{"key":"774_CR71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/v11010059","volume":"11","author":"Z Song","year":"2019","unstructured":"Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11:59.","journal-title":"Viruses"},{"key":"774_CR72","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1016\/j.vaccine.2006.10.031","volume":"25","author":"L Du","year":"2007","unstructured":"Du L, Zhao G, He Y, Guo Y, Zheng BJ, Jiang S, et al. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model. Vaccine. 2007;25:2832\u20138.","journal-title":"Vaccine"},{"key":"774_CR73","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.4049\/jimmunol.176.10.6085","volume":"176","author":"Y He","year":"2006","unstructured":"He Y, Li J, Li W, Lustigman S, Farzan M, Jiang S. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. J Immunol. 2006;176:6085\u201392.","journal-title":"J Immunol"},{"key":"774_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"Z Liu","year":"2020","unstructured":"Liu Z, Xu W, Xia S, Gu C, Wang X, Wang Q, et al. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target Ther. 2020;5:1.","journal-title":"Signal Transduct Target Ther"},{"key":"774_CR75","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","volume":"586","author":"NB Mercado","year":"2020","unstructured":"Mercado NB, Zahn R, Wegmann F, Loos C, Chandrashekar A, Yu J, et al. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature. 2020;586:583\u20138.","journal-title":"Nature"},{"key":"774_CR76","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.chom.2020.08.002","volume":"28","author":"G Dagotto","year":"2020","unstructured":"Dagotto G, Yu JY, Barouch DH. Approaches and challenges in SARS-CoV-2 vaccine development. Cell Host Microbe. 2020;28:364\u201370.","journal-title":"Cell Host Microbe"},{"key":"774_CR77","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","volume":"184","author":"WF Garcia-Beltran","year":"2021","unstructured":"Garcia-Beltran WF, Lam EC, St Denis K, Nitido AD, Garcia ZH, Hauser BM, et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021;184:2372\u201383.e9.","journal-title":"Cell"},{"key":"774_CR78","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","volume":"27","author":"D Planas","year":"2021","unstructured":"Planas D, Bruel T, Grzelak L, Guivel-Benhassine F, Staropoli I, Porrot F, et al. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nat Med. 2021;27:917\u201324.","journal-title":"Nat Med"},{"key":"774_CR79","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","volume":"20","author":"S Bournazos","year":"2020","unstructured":"Bournazos S, Gupta A, Ravetch JV. The role of IgG Fc receptors in antibody-dependent enhancement. Nat Rev Immunol. 2020;20:633\u201343.","journal-title":"Nat Rev Immunol"},{"key":"774_CR80","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science. 2010;328:745\u20138.","journal-title":"Science"},{"key":"774_CR81","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","volume":"379","author":"S Sridhar","year":"2018","unstructured":"Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med. 2018;379:327\u201340.","journal-title":"N Engl J Med"},{"key":"774_CR82","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.micinf.2020.02.006","volume":"22","author":"JA Tetro","year":"2020","unstructured":"Tetro JA. Is COVID-19 receiving ADE from other coronaviruses? Microbes Infect. 2020;22:72\u201373.","journal-title":"Microbes Infect"},{"key":"774_CR83","doi-asserted-by":"publisher","first-page":"e02015","DOI":"10.1128\/JVI.02015-19","volume":"94","author":"Y Wan","year":"2020","unstructured":"Wan Y, Shang J, Sun S, Tai W, Chen J, Geng Q, et al. Molecular mechanism for antibody-dependent enhancement of coronavirus entry. J Virol. 2020;94:e02015\u201319.","journal-title":"J Virol"},{"key":"774_CR84","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1016\/j.vaccine.2016.04.083","volume":"34","author":"BS Graham","year":"2016","unstructured":"Graham BS. Vaccines against respiratory syncytial virus: the time has finally come. Vaccine. 2016;34:3535\u201341.","journal-title":"Vaccine"},{"key":"774_CR85","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1203\/PDR.0b013e3180686ce0","volume":"62","author":"FP Polack","year":"2007","unstructured":"Polack FP. Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple. Pediatr Res. 2007;62:111\u20135.","journal-title":"Pediatr Res"},{"key":"774_CR86","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.micinf.2020.03.005","volume":"22","author":"A Sharma","year":"2020","unstructured":"Sharma A. It is too soon to attribute ADE to COVID-19. Microbes Infect. 2020;22:158.","journal-title":"Microbes Infect"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00774-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00774-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00774-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T12:06:32Z","timestamp":1675771592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00774-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["774"],"URL":"https:\/\/doi.org\/10.1038\/s41423-021-00774-w","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]},"assertion":[{"value":"29 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}